371 related articles for article (PubMed ID: 32259540)
1. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
[TBL] [Abstract][Full Text] [Related]
3. IgE-cross-blocking antibodies to Fagales following sublingual immunotherapy with recombinant Bet v 1.
Grilo JR; Kitzmüller C; Aglas L; Sánchez Acosta G; Vollmann U; Ebner C; Horak F; Kinaciyan T; Radauer C; Ferreira F; Jahn-Schmid B; Bohle B
Allergy; 2021 Aug; 76(8):2555-2564. PubMed ID: 33724487
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Birch Pollen Immunotherapy on Apple and rMal d 1 Challenges in Adults with Apple Allergy.
van der Valk JPM; Nagl B; van Wljk RG; Bohle B; de Jong NW
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32085633
[TBL] [Abstract][Full Text] [Related]
5. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
6. IgE, IgG4 and IgA specific to Bet v 1-related food allergens do not predict oral allergy syndrome.
Guhsl EE; Hofstetter G; Lengger N; Hemmer W; Ebner C; Fröschl R; Bublin M; Lupinek C; Breiteneder H; Radauer C
Allergy; 2015 Jan; 70(1):59-66. PubMed ID: 25327982
[TBL] [Abstract][Full Text] [Related]
7. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen-allergic patients with apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Kopp S; Wolkersdorfer M; Bohle B
Allergy; 2016 Feb; 71(2):272-4. PubMed ID: 26443126
[TBL] [Abstract][Full Text] [Related]
9.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
10. Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes.
Brazhnikov G; Smolnikov E; Litovkina A; Jiang T; Shatilov A; Tulaeva I; Tulaev M; Karaulov A; Poroshina A; Zhernov Y; Focke-Tejkl M; Weber M; Akinfenwa O; Elisyutina O; Andreev S; Shilovskiy I; Shershakova N; Smirnov V; Fedenko E; Lepeshkova TS; Beltyukov EC; Naumova VV; Kundi M; Khaitov M; Wiedermann U; Valenta R; Campana R
Allergy; 2023 Dec; 78(12):3136-3153. PubMed ID: 37701941
[TBL] [Abstract][Full Text] [Related]
11. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
[TBL] [Abstract][Full Text] [Related]
12. Effect of Lactobacillus rhamnosus GG on rBet v1 and rMal d1 specific IgA in the saliva of patients with birch pollen allergy.
Piirainen L; Haahtela S; Helin T; Korpela R; Haahtela T; Vaarala O
Ann Allergy Asthma Immunol; 2008 Apr; 100(4):338-42. PubMed ID: 18450119
[TBL] [Abstract][Full Text] [Related]
13. Clinical benefit of component-resolved diagnosis in Japanese birch-allergic patients with a convincing history of apple or peach allergy.
Shirasaki H; Yamamoto T; Abe S; Kanaizumi E; Kikuchi M; Himi T
Auris Nasus Larynx; 2017 Aug; 44(4):442-446. PubMed ID: 27816237
[TBL] [Abstract][Full Text] [Related]
14. Birch pollen immunotherapy inhibits anaphylaxis to the cross-reactive apple allergen Mal d 1 in mice.
Utsch L; Logiantara A; Wallner M; Hofer H; van Ree R; van Rijt LS
Clin Exp Allergy; 2016 Nov; 46(11):1474-1483. PubMed ID: 27376790
[TBL] [Abstract][Full Text] [Related]
15. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China.
Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD
J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268
[TBL] [Abstract][Full Text] [Related]
16. Sensitization profiles in birch pollen-allergic patients with and without oral allergy syndrome to apple: lessons from multiplexed component-resolved allergy diagnosis.
Ebo DG; Bridts CH; Verweij MM; De Knop KJ; Hagendorens MM; De Clerck LS; Stevens WJ
Clin Exp Allergy; 2010 Feb; 40(2):339-47. PubMed ID: 19709127
[TBL] [Abstract][Full Text] [Related]
17. Two different profiles of peach allergy in the north of Spain.
Gamboa PM; Cáceres O; Antepara I; Sánchez-Monge R; Ahrazem O; Salcedo G; Barber D; Lombardero M; Sanz ML
Allergy; 2007 Apr; 62(4):408-14. PubMed ID: 17362252
[TBL] [Abstract][Full Text] [Related]
18. Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells.
Fritsch R; Bohle B; Vollmann U; Wiedermann U; Jahn-Schmid B; Krebitz M; Breiteneder H; Kraft D; Ebner C
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):679-86. PubMed ID: 9802379
[TBL] [Abstract][Full Text] [Related]
19. Recombinant PreS-fusion protein vaccine for birch pollen and apple allergy.
Khaitov M; Shilovskiy I; Valenta R; Weber M; Korneev A; Tulaeva I; Gattinger P; van Hage M; Hofer G; Konradsen JR; Keller W; Akinfenwa O; Poroshina A; Ilina N; Fedenko E; Elisyutina O; Litovkina A; Smolnikov E; Nikonova A; Rybalkin S; Aldobaev V; Smirnov V; Shershakova N; Petukhova O; Kudlay D; Shatilov A; Timofeeva A; Campana R; Udin S; Skvortsova V
Allergy; 2024 Apr; 79(4):1001-1017. PubMed ID: 37855043
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1.
Mahler V; Vrtala S; Kuss O; Diepgen TL; Suck R; Cromwell O; Fiebig H; Hartl A; Thalhamer J; Schuler G; Kraft D; Valenta R
Clin Exp Allergy; 2004 Jan; 34(1):115-22. PubMed ID: 14720271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]